Just before the COVID-19 pandemic hit South Africa, the Mediclinic group has been planning a country-wide expansion of their facilities. These would include extra rooms for patients, additional equipment for the emergency wards, new operating theatres amongst others. The cost of this expansion was estimated at R650 million rand. The expansion plan was announced to the market and the net market reaction was positive as the share price by 15%. However, while this was being considered the new NHI scheme was being initiated in South Africa at the same time. Due to this regulatory intervention, all expansions were paused. The new expansion is now being regarded as a risk that the business cannot afford if the NHI is launched due to policy uncertainty. 3.1 (10 marks) Identify at least five (5) risks (including at least one (1) opportunity and at least one (1) hazard risk) that the Mediclinic group will face and propose controls for these risks. 3.2 Propose a potential risk significance scorecard that the group can use to assess the risks above. (10 marks)